Biovica Q3: Expanding market reach and increased sales support - Redeye
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Jämför själv: SAVR vs. Nordnet – så mycket kan du sänka dina avgifter för aktier och fonder (annons)

Aktieanalys

Biovica Q3: Expanding market reach and increased sales support - Redeye

{newsItem.title}
Redeye Publicerad: Igår 12:45
Biovica

Biovica records IVD test sales in Q3 of SEK 0.74m (460% above Q3 last year) and total sales of SEK 2.3m after adding ROU sales (test and services). More importantly, Biovica has doubled Pharma service orders to SEK 25m and expanded the US market reach significantly lately. This progress is also much needed considering that Biovica is still far off breakeven sales levels with a stretched cash position.

Länk till analysen i sin helhet: https://www.redeye.se/research/1088335/biovica-q3-expanding-market-reach-and-increased-sales-support?utm_source=finwire&utm_medium=RSS

Nyheter om Biovica

Läses av andra just nu

Om aktien Biovica

Senaste nytt